Case Report
Urinary Aspergillosis in a Patient with Systemic Lupus Erythematosus (SLE)
Table 1
Laboratory markers at diagnosis (september 2021), midtreatment (november 2021), and end of treatment (december 2021).
| | September 2021 | November 2021 | December 2021 | Reference range |
| The red blood cell indices | Erythrocytes | 2.81·106/μL | 3.22·106/μL | 3.75·106/μ | 4.00–5.20·106/μL | Hemoglobin | 7.2 g/dL | 8.3 g/dL | 9.4 g/dL | 12.0–16.0 g/dL | Haematocrit | 22% | 25% | 29% | 36.0–46.0% | Leukogram | 10.500/μL | 9.500/μL | 10.100/µL | 4.500–11.000/μL | C-reactive protein | 15.07 mg/dL | 13.56 mg/dL | 9.29 mg/dL | <0.30 mg/dL | Dosage voriconazole | | 3.3 mg/L | | 2.0–5.0 mg/L |
|
|